Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01222156

Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping (RICTAM)

Remote Intracardiac Catheter Target Acquisition Using the Magnetecs Catheter Guidance Control and Imaging (CGCI) System

Sponsor: Magnetecs Corporation

Conditions Tachycardia, Supraventricular Tachycardia, Ventricular

Interventions Magnetecs Catheter Guidance Control and Imaging system Remote magnetic navigation

Updated 6 times since 2017 Last updated: Oct 15, 2010 Started: Oct 31, 2010 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Tachycardia, Supraventricular and Tachycardia, Ventricular, this trial is ongoing. The trial is conducted by Magnetecs Corporation and has accumulated 6 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Magnetecs Corporation

Data source: Magnetecs Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain